Blau Farmacêutica Investor Relations Material
Latest events
Q2 2025
Blau Farmacêutica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Blau Farmacêutica S.A
Access all reports
Blau Farmacêutica S.A. develops and manufactures pharmaceuticals with a focus on biotechnology-based products. Its portfolio includes hospital-use medications and therapies for oncology, nephrology, and infectious diseases. The company is headquartered in Cotia, Brazil, and its shares are listed on the B3.
Key slides for Blau Farmacêutica S.A
Q2 2025
Blau Farmacêutica S.A
Q1 2025
Blau Farmacêutica S.A
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
BLAU3
Country
🇧🇷 Brazil